Life-threatening angioedema induced by angiotensin-converting enzyme inhibitors: Characteristics and risk factors

American Journal of Rhinology and Allergy

Volumn 28, Issue 1, 2014, Pages 54-58

  Stauber, Tali ^a   Confino Cohen, Ronit ^a,b   Goldberg, Arnon ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOTHYROXINE SODIUM; STEROID; VASODILATOR AGENT;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTUBATION; MALE; MIDDLE AGED; OBESITY; RISK FACTOR; AGED; CHEMICALLY INDUCED; CRITICAL ILLNESS; DIABETES MELLITUS; EMERGENCY HEALTH SERVICE; MORTALITY; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGED; ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CRITICAL ILLNESS; DIABETES MELLITUS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84893365676     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2014.28.3989     Document Type: Article

References (18)

1. Makani H, Bangalore S, Desouza KA, et al. Efficacy and safety of dual blockade of the renin-angiotensin system: Meta-analysis of randomised trials. BMJ 346:f360, 2013. (DOI: 10.1136/bmj.f360.)
2. Miller DR, Oliveria SA, Berlowitz DR, et al. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension 51:1624-1630, 2008.
3. Vasekar M, and Craig TJ. ACE inhibitor-induced angioedema. Curr Allergy Asthma Rep 12:72-78, 2012.
4. Banerji A, Clark S, Blanda M, et al. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 100:327-332, 2008. (Pubitemid 351520323)
5. Tai S, Mascaro M, and Goldstein NA. Angioedema: A review of 367 episodes presenting to three tertiary care hospitals. Ann Otol Rhinol Laryngol 119:836-841, 2010.
6. Roberts JR, Lee JJ, and Marthers DA. Angiotensin-converting enzyme (ACE) inhibitor angioedema: The silent epidemic. Am J Cardiol 109:774-775, 2012.
7. Lin RY, Levine RJ, and Lin H. Adverse drug effects and angioedema hospitalizations in the United States from 2000 to 2009. Allergy Asthma Proc 34:65-71, 2013.
8. Al-Khudari S, Loochtan MJ, Peterson E, ad Yaremchuk KL. Management of angiotensin-converting enzyme inhibitor-induced angioedema. Laryngoscope 121:2327-2334, 2011.
9. Grant NN, Deeb ZE, and Chia SH. Clinical experience with angiotensin-converting enzyme inhibitor-induced angioedema. Otolaryngol Head Neck Surg 137:931-935, 2007. (Pubitemid 350117072)
10. Makani H, Messerli FH, Romero J, et al. Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol 110:383-391, 2012.
11. Gang C, Lindsell CJ, Moellman J, et al. Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedema. Allergy Asthma Proc 34:267-273, 2013.
12. Jain M, Armstrong L, and Hall J. Predisposition to and late onset of upper airway obstruction following angiotensin-converting enzyme inhibitor therapy. Chest 102:871-874, 1992.
13. Stojiljkovic L. Renin-angiotensin system inhibitors and angioedema: Anesthetic implications. Curr Opin Anaesthesiol 25:356-362, 2012.
14. Beltrami L, Zanochelli A, Zingale L, et al. Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema. J Hypertens 29:2273-2277, 2011.
15. Byrd JB, Touzin K, Sile S, et al. Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema. Hypertension 51:141-147, 2008. (Pubitemid 350307116)
16. Gandhi PK, Gentry WM, and Bottorff MB. Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: Investigation from the United States Food and Drug Administration adverse event reporting system database. Pharmacotherapy 32:902-909, 2012.
17. Cugno M, Asero R, Tedeschi A, et al. Inflammation and coagulation in urticaria and angioedema. Curr Vasc Pharmacol 10:653-658, 2012.
18. Bernstein JA. Update on angioedema: Evaluation, diagnosis and treatment. Allergy Asthma Proc 32:408-412, 2011.